Hearing loss in muckle-wells syndrome

Arthritis and Rheumatism

Volumn 65, Issue 3, 2013, Pages 824-831

  Kuemmerle Deschner, Jasmin B ^a   Koitschev, Assen ^b   Ummenhofer, Katharina ^c   Hansmann, Sandra ^a   Plontke, Stefan K ^c   Koitschev, Christiane ^a   Koetter, Ina ^a   Angermair, Eva ^a   Benseler, Susanne M ^d  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b KLINIKUM STUTTGART   (Germany)

^c MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUDIOLOGIC ANALYSIS; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HEARING IMPAIRMENT; HEARING TEST; HUMAN; MALE; MUCKLE WELLS SYNDROME; NEURO OTOLOGIC TESTING; NLRP3 GENE; PERCEPTION DEAFNESS; PRESCHOOL CHILD; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; SCHOOL CHILD; TINNITUS; VESTIBULAR ORGAN TESTING;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; AUDIOMETRY, PURE-TONE; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEARING LOSS, SENSORINEURAL; HUMANS; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 84874408867     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37810     Document Type: Article

References (32)

1. Muckle TJ, Wells M,. Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome. Q J Med 1962; 31: 235-48.
2. Stojanov S, Kastner DL,. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005; 17: 586-99.
3. Aksentijevich I, Nowak M, Mallah M, Chae JJ, Watford WT, Hofmann SR, et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum 2002; 46: 3340-8.
4. Prieur AM, Griscelli C, Lampert F, Truckenbrodt H, Guggenheim MA, Lovell DJ, et al. A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome: a specific entity analysed in 30 patients. Scand J Rheumatol Suppl 1987; 66: 57-68.
5. Hawkins PN, Lachmann HJ, Aganna E, McDermott MF,. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 2004; 50: 607-12.
6. Kanneganti TD, Body-Malapel M, Amer A, Park JH, Whitfield J, Franchi L, et al. Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J Biol Chem 2006; 281: 36560-8.
7. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006; 440: 228-32.
8. Martinon F, Mayor A, Tschopp J,. The inflammasomes: guardians of the body. Annu Rev Immunol 2009; 27: 229-65.
9. Dinarello CA,. Biologic basis for interleukin-1 in disease. Blood 1996; 87: 2095-147.
10. Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J,. NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004; 20: 319-25.
11. Janssen R, Verhard E, Lankester A, Ten Cate R, van Dissel JT,. Enhanced interleukin-1β and interleukin-18 release in a patient with chronic infantile neurologic, cutaneous, articular syndrome. Arthritis Rheum 2004; 50: 3329-33.
12. Goldbach-Mansky R, Dailey NJ, Canna SW, Gelabert A, Jones J, Rubin BI, et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1β inhibition. N Engl J Med 2006; 355: 581-92.
13. Hoffman HM, Throne ML, Amar NJ, Sebai M, Kivitz AJ, Kavanaugh A, et al. Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. Arthritis Rheum 2008; 58: 2443-52.
14. Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, Leslie KS, Hachulla E, Quartier P, et al. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med 2009; 360: 2416-25.
15. Mirault T, Launay D, Cuisset L, Hachulla E, Lambert M, Queyrel V, et al. Recovery from deafness in a patient with Muckle- Wells syndrome treated with anakinra. Arthritis Rheum 2006; 54: 1697-700.
16. Rynne M, Maclean C, Bybee A, McDermott MF, Emery P,. Hearing improvement in a patient with variant Muckle-Wells syndrome in response to interleukin 1 receptor antagonism. Ann Rheum Dis 2006; 65: 533-4.
17. Klein AK, Horneff G,. Improvement of sensoneurinal hearing loss in a patient with Muckle-Wells syndrome treated with anakinra. Klin Padiatr 2010; 222: 266-8. In German.
18. Yamazaki T, Masumoto J, Agematsu K, Sawai N, Kobayashi S, Shigemura T, et al. Anakinra improves sensory deafness in a Japanese patient with Muckle-Wells syndrome, possibly by inhibiting the cryopyrin inflammasome. Arthritis Rheum 2008; 58: 864-8.
19. Chau JK, Lin JR, Atashband S, Irvine RA, Westerberg BD,. Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss. Laryngoscope 2010; 120: 1011-21.
20. Wormald R, Viani L, Lynch SA, Green AJ,. Sensorineural hearing loss in children. Ir Med J 2010; 103: 51-4.
21. Merchant SN, Adams JC, Nadol JB Jr,. Pathology and pathophysiology of idiopathic sudden sensorineural hearing loss. Otol Neurotol 2005; 26: 151-60.
22. National Library of Medicine: National Institutes of Health. Genetics Home Reference: nonsyndromic deafness. November 2006. URL: http://ghr.nlm.nih. gov/condition/nonsyndromic-deafness.
23. Spoor A,. Presbycusis values in relation to noise induced hearing loss. Int J Audiol 1967; 6: 48-57.
24. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD,. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001; 29: 301-5.
25. Goebel G, Hiller W,. The tinnitus questionnaire: a standard instrument for grading the degree of tinnitus: results of a multicenter study with the tinnitus questionnaire. HNO 1994; 42: 166-72. In German.
26. Yoshioka M, Uchida Y, Sugiura S, Ando F, Shimokata H, Nomura H, et al. The impact of arterial sclerosis on hearing with and without occupational noise exposure: a population-based aging study in males. Auris Nasus Larynx 2010; 37: 558-64.
27. Albera R, Lacilla M, Piumetto E, Canale A,. Noise-induced hearing loss evolution: influence of age and exposure to noise. Eur Arch Otorhinolaryngol 2010; 267: 665-71.
28. George DL, Pradhan S,. Idiopathic sensorineural hearing disorders in adults-a pragmatic approach. Nat Rev Rheumatol 2009; 5: 505-12.
29. Ahmadi N, Brewer CC, Zalewski C, King KA, Butman JA, Plass N, et al. Cryopyrin-associated periodic syndromes: otolaryngologic and audiologic manifestations. Otolaryngol Head Neck Surg 2011; 145: 295-302.
30. Karmody CS, Valdez TA, Desai U, Blevins NH,. Sensorineural hearing loss in patients with inflammatory bowel disease. Am J Otolaryngol 2009; 30: 166-70.
31. Neven B, Marvillet I, Terrada C, Ferster A, Boddaert N, Couloignier V, et al. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome. Arthritis Rheum 2010; 62: 258-67.
32. Dode C, Le Du N, Cuisset L, Letourneur F, Berthelot JM, Vaudour G, et al. New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes. Am J Hum Genet 2002; 70: 1498-506.